Filter by: patients
What is Gc Protein-derived Macrophage Activating Factor (GcMAF)?

Gc Protein-derived Macrophage Activating Factor (GcMAF)Serum Gc protein (known as vitamin D3-binding protein) is the precursor for the principal macrophage activating factor (MAF). It is being tested for use in cancer and HIV treatment.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 1 1 Efficacy_cant_tell

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
1
None
0

Commonly reported side effects, conditions, and hospitalizations associated with Gc Protein-derived Macrophage Activating Factor (GcMAF)

Headaches with eye discomfort 1

Reported Stop Reasons

Why Patients Stopped Taking Gc Protein-derived Macrophage Activating Factor (GcMAF) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Gc Protein-derived Macrophage Activating Factor (GcMAF)

Stopped Taking Gc Protein-derived Macrophage Activating Factor (GcMAF)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Gc Protein-derived Macrophage Activating Factor (GcMAF)

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Gc Protein-derived Macrophage Activating Factor (GcMAF)

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

Cost of Gc Protein-derived Macrophage Activating Factor (GcMAF)

$200+
1 100%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on May 26, 2012.